
Outlive
- #1 NEW YORK TIMES BESTSELLER
Outlive by Peter Attia is one of 2026's most credible books, appearing on 1 of the year's most respected lists, including McKinsey & Company, for a Consensus Score of 12 out of 100.
Appears on these lists
Our take
AI-draftedAttia's case rests on reframing medicine around preventing the four chronic diseases that actually kill most people rather than reacting once they're diagnosed, and pairing that with fairly aggressive personal targets, LDL cholesterol far below conventional guidelines, extensive testing, and a heavy emphasis on structured exercise for what he calls the "Centenarian Decathlon." The most substantive criticism has been about who can actually use this advice: DEXA scans, continuous glucose monitors, and personal trainers assume a level of time and money most readers don't have, and the mental health chapter is noticeably thinner than the physiology-heavy chapters around it. Even critics who disagree with specific numbers, particularly the cholesterol targets, generally credit the underlying science as more rigorous than the typical longevity book.
How the Consensus Score is calculated
Our Consensus Score is our own transparent editorial metric — not a user rating. It weighs each list by the credibility of its source, how recent the listing is, and any award status. Here is the full breakdown.
| Source | Authority | Recency | Award | Contribution |
|---|---|---|---|---|
| McKinsey & Company | 0.80 | 0.70 | 1.00× | 0.56 |
| Weighted sum → Score | 0.56 → 12 | |||
Similar consensus books
Because they appear on some of the same lists.
Frequently asked
What lists is Outlive on?
Outlive appears on 1 list in our 2026 corpus, including McKinsey & Company.
What is its Consensus Score?
Outlive has a Consensus Score of 12 out of 100, our transparent editorial measure of how many credible lists agree on it.



